| 產(chǎn)品名稱 | Valdecoxib - SC 65872 | Bextra |
| 產(chǎn)品貨號 | Axon 2106 CAS [181695-72-7] MF C16H14N2O3SMW 314.36 Purity: 99% Soluble in DMSO Description NSAID. Highly selective and potent inhibitor of COX-2 in human whole blood and against the recombinant human enzyme, showing exceptional potency after oral administration. Valdecoxib showed weak inhibitory activity against COX-1 (IC50 = 140 μM), and potent activity against COX-2 (IC50 = 0.005 μM) References Certificates Categories Extra info JJ Talley et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J. Med. Chem. 2000, 43(5), 775-777.? Certificate of Analysis Material Safety Data Sheet CNS Immunology Pain & Inflammation EC 1.14.99.1 COX Pfizer Licensed Products Selecive COX-2 inhibitor Chemical name 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [181695-72-7] Order Size Unit Price Stock 10 mg €80.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Valdecoxib - SC 65872 | BextraAxon 2106 CAS [181695-72-7] MF C16H14N2O3S
Description
NSAID. Highly selective and potent inhibitor of COX-2 in human whole blood and against the recombinant human enzyme, showing exceptional potency after oral administration. Valdecoxib showed weak inhibitory activity against COX-1 (IC50 = 140 μM), and potent activity against COX-2 (IC50 = 0.005 μM)
Selecive COX-2 inhibitor
Chemical name4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[181695-72-7] |
| 產(chǎn)品資料 |
